JP2013545794A5 - - Google Patents

Download PDF

Info

Publication number
JP2013545794A5
JP2013545794A5 JP2013543872A JP2013543872A JP2013545794A5 JP 2013545794 A5 JP2013545794 A5 JP 2013545794A5 JP 2013543872 A JP2013543872 A JP 2013543872A JP 2013543872 A JP2013543872 A JP 2013543872A JP 2013545794 A5 JP2013545794 A5 JP 2013545794A5
Authority
JP
Japan
Prior art keywords
agent
dispersant
product
adhesion inhibitor
antibacterial agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013543872A
Other languages
English (en)
Other versions
JP5964854B2 (ja
JP2013545794A (ja
Filing date
Publication date
Priority claimed from GBGB1021186.0A external-priority patent/GB201021186D0/en
Application filed filed Critical
Publication of JP2013545794A publication Critical patent/JP2013545794A/ja
Publication of JP2013545794A5 publication Critical patent/JP2013545794A5/ja
Application granted granted Critical
Publication of JP5964854B2 publication Critical patent/JP5964854B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (1)

  1. 抗菌剤と、分散剤または接着阻害剤である第二薬剤とを含有してなる製造品。
JP2013543872A 2010-12-14 2011-12-14 抗菌剤と分散剤または接着阻害剤組成物 Active JP5964854B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42300010P 2010-12-14 2010-12-14
GB1021186.0 2010-12-14
GBGB1021186.0A GB201021186D0 (en) 2010-12-14 2010-12-14 Composition
US61/423,000 2010-12-14
PCT/GB2011/001721 WO2012080700A1 (en) 2010-12-14 2011-12-14 A composition comprising an antibiotic and a dispersant or an anti -adhesive agent

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016129761A Division JP6483058B2 (ja) 2010-12-14 2016-06-30 抗菌剤と分散剤または接着阻害剤組成物

Publications (3)

Publication Number Publication Date
JP2013545794A JP2013545794A (ja) 2013-12-26
JP2013545794A5 true JP2013545794A5 (ja) 2015-02-05
JP5964854B2 JP5964854B2 (ja) 2016-08-03

Family

ID=43567164

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013543872A Active JP5964854B2 (ja) 2010-12-14 2011-12-14 抗菌剤と分散剤または接着阻害剤組成物
JP2016129761A Active JP6483058B2 (ja) 2010-12-14 2016-06-30 抗菌剤と分散剤または接着阻害剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016129761A Active JP6483058B2 (ja) 2010-12-14 2016-06-30 抗菌剤と分散剤または接着阻害剤組成物

Country Status (28)

Country Link
US (3) US9782423B2 (ja)
EP (2) EP2651419B1 (ja)
JP (2) JP5964854B2 (ja)
KR (1) KR101955636B1 (ja)
CN (1) CN103732232B (ja)
AU (3) AU2011343012C1 (ja)
BR (2) BR122019015601B1 (ja)
CA (1) CA2821032C (ja)
CY (2) CY1117447T1 (ja)
DK (2) DK2651419T3 (ja)
ES (2) ES2565564T3 (ja)
GB (1) GB201021186D0 (ja)
HK (2) HK1185015A1 (ja)
HR (2) HRP20160235T1 (ja)
HU (2) HUE027207T2 (ja)
IL (2) IL226879B (ja)
LT (1) LT3040076T (ja)
MX (1) MX346664B (ja)
NZ (1) NZ613076A (ja)
PL (2) PL2651419T3 (ja)
PT (1) PT3040076T (ja)
RS (2) RS54815B1 (ja)
RU (2) RU2739249C2 (ja)
SG (3) SG191146A1 (ja)
SI (2) SI2651419T1 (ja)
SM (1) SMT201600121B (ja)
UA (1) UA114470C2 (ja)
WO (1) WO2012080700A1 (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2684150C (en) 2007-05-14 2016-10-04 Research Foundation Of State University Of New York Decenoic acid dispersion inducers in the treatment of biofilms
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
PT106094A (pt) 2012-01-13 2013-07-15 Hovione Farmaciencia S A Administração por inalação de formulações com dose elevada
US20150273025A1 (en) * 2012-09-28 2015-10-01 The Regents Of The University Of Michigan Apyrase treatments
GB201416727D0 (en) * 2014-09-22 2014-11-05 Novabiotics Ltd Use
GB201416716D0 (en) * 2014-09-22 2014-11-05 Novabiotics Ltd Use
US10617703B2 (en) 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
GB201510077D0 (en) * 2015-06-10 2015-07-22 Novabiotics Ltd Use
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898491B2 (en) 2015-12-18 2021-01-26 Cmpd Licensing, Llc Compositions and methods for treating an infection
US10898455B2 (en) 2016-01-07 2021-01-26 Cmpd Licensing, Llc Urea cream formulations
US11278590B2 (en) 2015-08-05 2022-03-22 Cmpd Licensing, Llc Compositions and methods for treating nail infections
US11690815B2 (en) 2015-08-05 2023-07-04 Cmpd Licensing Llc Hyperkeratotic skin condition treatments and compositions
GB2565511B (en) 2016-05-26 2022-04-13 Kimberly Clark Co Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
US10905660B2 (en) 2016-06-07 2021-02-02 Novabiotics Limited Microparticles
WO2017212239A1 (en) * 2016-06-07 2017-12-14 Novabiotics Limited Treatment of drug-resistant microbial infections
GB201609940D0 (en) * 2016-06-07 2016-07-20 Novabiotics Ltd Microparticles
US11576871B2 (en) 2016-11-16 2023-02-14 The Regents Of The University Of California Formulations of cysteamine and cystamine
US9999604B2 (en) 2016-11-17 2018-06-19 Cmpd Licensing, Llc Compounded solutions of diclofenac and lidocaine and methods
US11986448B2 (en) 2016-11-17 2024-05-21 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10525025B2 (en) 2016-11-17 2020-01-07 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US11737975B2 (en) 2016-11-17 2023-08-29 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
US10966946B2 (en) 2016-11-17 2021-04-06 Cmpd Licensing, Llc Compounded compositions and methods for treating pain
HRP20230369T1 (hr) * 2016-12-15 2023-06-23 Zambon S.P.A. N-acetilcistein za uporabu kao antibakterijsko sredstvo
EP3366284A1 (en) * 2017-02-27 2018-08-29 Zambon S.p.A. Association of n-acetylcysteine and colistin for use in bacterial infections
JP2020513041A (ja) * 2017-04-10 2020-04-30 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ 病原体の阻害および／または粘液の改変のための化合物、組成物、および方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020079186A1 (en) * 2018-10-17 2020-04-23 Novabiotics Limited Dosage regime
WO2021022012A1 (en) * 2019-07-30 2021-02-04 The Regents Of The University Of California Methods and composition for treating respiratory obstructive diseases
CN111053696B (zh) * 2019-11-19 2022-11-04 温州医科大学附属口腔医院 一种抑制细菌粘附的超疏水凝胶纳米涂层及制备方法
CN113018443B (zh) * 2019-12-27 2022-09-13 海南斯达制药有限公司 治疗呼吸系统疾病的药物组合物及其制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055560B (it) 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
IT1178869B (it) 1984-03-07 1987-09-16 Cagliero Germano Prodotto per prevenire e combattere le tossicosi alimentari dovute a micotossine
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
WO1994007529A1 (en) 1992-09-25 1994-04-14 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3749279B2 (ja) 1995-03-01 2006-02-22 日産化学工業株式会社 爪用抗真菌剤
US5624704A (en) * 1995-04-24 1997-04-29 Baylor College Of Medicine Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
AU2042200A (en) 1998-12-07 2000-06-26 Baylor College Of Medicine Preventing and removing biofilm from the surface of medical devices
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
ITMI20021881A1 (it) 2002-09-04 2004-03-05 Zambon Spa Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario.
GB2398497A (en) 2003-02-19 2004-08-25 Walcom Animal Science Composition for improving immunity of animals
ATE515261T1 (de) 2003-12-19 2011-07-15 Omega Bio Pharma Ip3 Ltd Zusammensetzungen zur behandlung von diabetes
EP3141559A1 (en) 2004-08-18 2017-03-15 Novabiotics Limited Antimicrobial peptides
WO2007050565A2 (en) * 2005-10-25 2007-05-03 Baylor College Of Medicine Incorporation of antimicrobial combinations onto devices to reduce infection
CN101340902B (zh) 2005-11-28 2011-01-26 奥加生物药业（香港）有限公司 用半胱胺化合物处理病毒感染的材料和方法
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
US20070172514A1 (en) * 2006-01-20 2007-07-26 Francis Chi Materials and methods for improving livestock productivity
DE102006010642A1 (de) 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
US20080035141A1 (en) * 2006-06-16 2008-02-14 Warner W R Aerosolized therapy kit
EP2099466B1 (en) * 2006-12-01 2015-06-03 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
US20080131500A1 (en) * 2006-12-04 2008-06-05 The Board Of Regents Of The University Of Texas System Methods and compositions for rapid inactivation of proteins
WO2008092262A1 (en) 2007-01-31 2008-08-07 The Royal Institution For The Advancement Of Learning/Mcgill University Methods and compounds for treatment, prevention and diagnosis of parasitic infection and disease
GB0702021D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
WO2008124706A2 (en) 2007-04-06 2008-10-16 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Devices and methods for target molecule characterization
EP1994930A1 (en) * 2007-05-22 2008-11-26 Novartis AG Triazol compounds for treating biofilm formation
RU2371447C2 (ru) * 2007-10-05 2009-10-27 Общество С Ограниченной Ответственностью "Саентифик Фьючер Менеджмент" Конъюгат антибиотика и антибактериальное лекарственное средство на его основе
WO2009076722A1 (en) 2007-12-19 2009-06-25 The University Of Melbourne Method of protecting a surface from biological fouling
WO2009086942A1 (en) * 2008-01-10 2009-07-16 Evonik Röhm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
WO2009100950A1 (en) 2008-02-17 2009-08-20 Walcom Animal Science (I.P.3) Limited Materials and methods for improving the health of shrimp
BRPI1007885A2 (pt) * 2009-02-03 2016-02-16 Microbion Corp bismuto-tóis antissépticos para tecidos epiteliais, feridas agudas e crônicas, biofilmes bacterianos e outras indicações
GB0905451D0 (en) * 2009-03-31 2009-05-13 Novabiotics Ltd Biofilms
US8815942B2 (en) * 2010-10-20 2014-08-26 The Royal Institution For The Advancement Of Learning/Mcgill University Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
GB201021186D0 (en) 2010-12-14 2011-01-26 Novabiotics Ltd Composition
US20150071904A1 (en) 2012-01-06 2015-03-12 Trustees Of Boston University Compositions and methods to boost endogenous ros production from bacteria
US20160106689A1 (en) 2014-09-22 2016-04-21 Novabiotics Limited Use

Similar Documents

Publication Publication Date Title
JP2013545794A5 (ja)
EP2679633A4 (en) Polylactic acid-based film
JP2013525942A5 (ja)
BRPI0923985A2 (pt) película multicamada e artigo fabricado
BRPI1010030A2 (pt) artigo polimérico revestido com metal
JP2014517741A5 (ja)
EP2969264A4 (en) ACOUSTIC TRANSDUCERS HAVING A BEND LIMITATION ELEMENT
JP2011170856A5 (ja)
JP2013543797A5 (ja)
EP3222614A4 (en) Biguanide compound and use thereof
DK2401917T3 (da) Belagte pulverartikler
JP2015501646A5 (ja)
JP2013538128A5 (ja)
FR2959505B1 (fr) Grains de mullite revetus.
PT2688572T (pt) Composição farmacêutica com um inibidor de hdac e um esteroide e sua utilização
EP2707222A4 (en) POLYMIC ACID BASED COATINGS AND USES THEREOF
GB2512413B (en) Acoustic echo cancellation
BR112012021368A2 (pt) revestimento aderente aplicado quente
FR2968601B1 (fr) Pneumatique ayant des bourrelets perfectionnes.
ITMI20120125A1 (it) Mandrino di serraggio
GB2512155B (en) Acoustic echo cancellation
EP2714716A4 (en) MATRIPTASE INHIBITORS AND USES THEREOF AGAINST ORTHOMYXOVIRIDAE INFECTIONS
BR112014008210A2 (pt) nanoespuma metálica antibacteriana e métodos relacionados
JP2012044147A5 (ja)
FI20105548A (fi) Robottikäsimekanismi